Cargando…
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Stem cell therapy is a promising alternative approach to heart diseases. The most prevalent source of multipotent stem cells, usually called somatic or adult stem cells (mesenchymal stromal/stem cells, MSCs) used in clinical trials is bone marrow (BM-MSCs), adipose tissue (AT-MSCs), umbilical cord (...
Autores principales: | Gubert, Fernanda, da Silva, Jaqueline Soares, Vasques, Juliana F., de Jesus Gonçalves, Renata Guedes, Martins, Robertta Silva, de Sá, Mauro Paes Leme, Mendez-Otero, Rosalia, Zapata-Sudo, Gisele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307175/ https://www.ncbi.nlm.nih.gov/pubmed/34299066 http://dx.doi.org/10.3390/ijms22147447 |
Ejemplares similares
-
Gangliosides in nervous system development, regeneration, and pathologies
por: Vasques, Juliana F., et al.
Publicado: (2022) -
Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges
por: Gonçalves, Renata Guedes de Jesus, et al.
Publicado: (2022) -
Heart Failure in Menopause: Treatment and New Approaches
por: da Silva, Jaqueline S., et al.
Publicado: (2022) -
Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
por: da Silva, Jaqueline S., et al.
Publicado: (2022) -
Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
por: da Silva, Marina de Moraes Carvalho, et al.
Publicado: (2020)